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The association between selenium status and risk of acute myocardial infarction was examined in a
multicenter case-control study in 10 centers from Europe and Israel in 1991-1992. Selenium in toenails was
assessed for 683 nonfatal male cases with first acute myocardial infarction and 729 controls less than 70 years
of age. Median toenail selenium content was 0.553 /xg/g for cases and 0.590 jxg/g for controls. After
adjustment for age, center, and smoking, the odds ratio for myocardial infarction in the highest quintile of
selenium as compared with the lowest was 0.63 (95 percent confidence interval 0.37-1.07, p for trend = 0.08).
The observed inverse trend was somewhat stronger when the authors adjusted for vitamin E status (p = 0.05).
Analysis stratified for smoking habits showed an inverse association in former smokers (odds ratio for the
75th-25th percentile contrast = 0.63 (95 percent confidence interval 0.43-0.94)), but not in current smokers
(odds ratio = 0.97 ( 0.71-1.32)) or in those who had never smoked (odds ratio = 1.55 (0.87-2.76)). Analysis
stratified by center showed a significant inverse association between selenium levels and risk of myocardial
infarction for Germany (Berlin) only (75th to 25th percentile odds ratio = 0.62 (95 percent confidence interval
0.42-0.91)), which was the center with the lowest selenium levels. It appears that the increased risk of acute
myocardial infarction at low levels of selenium intake is largely explained by cigarette smoking; selenium status
does not appear to be an important determinant of risk of myocardial infarction at the levels observed in a large
part of Europe. Am J Epidemiol 1997;145:373-9.
antioxidants; case-control studies; myocardial infarction; selenium
Evidence is accumulating that oxidation of low den-
sity lipoprotein particles and cytotoxic effects of lipid
peroxides enhance the formation of foam cells and
atherosclerotic lesions (1, 2). Selenium is part of the
enzyme glutathione peroxidase, which plays an impor-
tant role in the antioxidant defense of the body against
the deleterious actions of free radicals and lipid per-
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oxides. The question of whether low selenium status
predisposes to cardiovascular disease has been ad-
dressed in a number of studies in the past decade
(3-10). In several prospective (3-5) and case-control
(6) studies, low serum selenium levels were associated
with increased risk of coronary heart disease. How-
ever, in other studies, this association could not be
confirmed (7-10). Antioxidant defense is achieved by
additive or synergistic action of enzymes and antiox-
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idant nutrients (11, 12). Selenium and vitamin E in
particular appear to have overlapping and partly com-
pensative functions (13-17). Therefore, it is conceiv-
able that the relation between selenium status and risk
of coronary heart disease is influenced by the status of
other antioxidants, as has been observed in an animal
experiment (18). This possible interactive effect has
scarcely been addressed in population studies. In a
prospective study, Kok et al. (8) reported no interac-
tion between serum selenium and serum vitamin E and
risk of cardiovascular death. However, in another
study (19), patients with severe atherosclerosis had
significantly lower plasma selenium levels (relative to
polyunsaturated fatty acids) than patients with mild
atherosclerosis, but only in the subgroup with low
plasma vitamin E status.
We have studied the association between selenium
and acute myocardial infarction in a case-control study
in nine different countries. The large variation in se-
lenium intake in these centers permits evaluation of a
dose-response relation; comparison of this relation
between populations will show whether it is consis-
tent. Selenium levels were measured in toenail clip-
pings, a biomarker of long-term intake not affected by
the acute event of the disease (20-22).
MATERIALS AND METHODS
Design and participants
The European Antioxidant Myocardial Infarction
and Breast Cancer (EURAMIC) Study was a multi-
center international case-control study (23, 24). To
evaluate the association of antioxidants with the risk of
developing a myocardial infarction, a total of 742
cases and 757 controls were recruited concurrently
during 1991 and 1992 in eight European countries and
Israel, according to the same eligibility criteria. Eligi-
ble individuals were men less than 70 years of age,
without previously reported myocardial infarction.
Persons were excluded if they had a history of drug or
alcohol abuse or major psychiatric disorders, if they
were institutionalized, or if they had modified their
dietary pattern (including supplement use) in the pre-
vious year. Cases were individuals who had received a
first acute myocardial infarction diagnosis (Interna-
tional Classification of Diseases, Ninth Revision, code
410), which was confirmed by specific electrocardio-
graphic abnormalities and elevated enzyme levels
(25), and who had been admitted within 24 hours of
manifesting symptoms. They were recruited from the
coronary care unit of participating hospitals. Individ-
uals without a history of myocardial infarction were
eligible as controls and were recruited from the pop-
ulation in the catchment area and frequency matched
for age according to 5-year intervals. If possible, ran-
dom samples from local population registries were
used (Finland, Israel, Germany, Scotland, Switzer-
land). In some centers (Russia, Spain), population
registries could not be used due to incomplete cover-
age or legal restrictions. Therefore, hospital controls
were selected, with diseases that were not known to be
associated with antioxidant status: noninfectious pros-
tatism, renal colic, hernia, acute appendicitis/acute
mesenteric adenitis, and volvulus/subocclusion due to
fibrosis, rectal/anal pathology (apart from cancer,
hemorrhoids, and chronic infections).
When it was anticipated that low response rates
from population-based samples would compromise in-
ternal validity, controls were selected from the catch-
ment area via a random sample by the patient's general
practitioner (Netherlands) or by inviting friends and
relatives of the case (Norway). In the Netherlands,
Russia, and Spain, recruitment methods were com-
bined. The overall response rates were 81 percent in
cases and 64 percent in controls (table 1). Informed
consent was obtained in accordance with the ethical
standards of the responsible committees on medical
research.
Information on smoking habits, history of hyperten-
sion, angina pectoris, and diabetes was collected by
standard questionnaires (26). Socioeconomic status,
family history, and alcohol intake were assessed
through locally developed questionnaires. Smoking
status was recorded as current, ex-, or never smoker;
for current smokers, the daily number of cigarettes
smoked was asked. Family history of coronary heart
disease was defined as mother, father, or sibling hav-
ing died of myocardial infarction or other heart dis-
ease, without specification of the person's age when
the event occurred.
A nonfasting blood sample was drawn not later than
24 hours after onset of symptoms. Serum total and
TABLE 1. Population response rate and method of control
recruitment in the EURAMIC Study, 1991-1992
Center
Finland (Helsinki)
Germany (Berlin)
Israel (Jerusalem)
Netherlands (Zeist)
Norway (Sarpsborg)
Russia (Moscow)
Scotland (Edinburgh)
Spain (Granada)
Spain (Malaga)
Switzerland (Zurich)
Cases
(response
%)
62(97)
77(82)
59 (60)
72(75)
101 (96)
100(97)
58(98)
57(45)
100 (89)
57(93)
Controls
(response
%)
61 (51)
97(73)
60(53)
63(50)
102 (98)
100(79)
43(61)
54(67)
102(77)
74 (26)
Method of
control
recruitment*
PR
PR
PR
GP, PR
FR
GP, H
PR
H
H, GP
PR
• PR, population register GP, general practitioners; H, hospital
controls; FR, friends, relatives.
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high density lipoprotein cholesterol levels were deter-
mined enzymatically with a Boehringer Mannheim kit
(Boehringer Mannheim GmbH, Mannheim, Germany)
at the National Public Health Institute in Helsinki,
Finland.
Subcutaneous adipose tissue was taken from the
buttock by needle aspiration (27). In cases, the adipose
sample was taken within 7 days of hospital admission.
Samples were stored at — 70°C and analyzed in a
central laboratory. Alpha-tocopherol and beta-
carotene were determined in the adipose tissue after
saponification by reverse-phase high performance liq-
uid chromatography and spectrophotometric detection
(28), with an overall coefficient of variation of 7
percent. Vitamin concentrations in adipose tissue were
expressed in /xg/g of total fatty acids. Fatty acid con-
tent was assessed by gas-liquid chromatography (29)
in an aliquot of the same extract as that of the vita-
mins, adding heptadecanoic acid (C17:0) as an internal
standard to the sample before saponification.
Selenium in toenails
Toenail clippings from all 10 toes were collected
within 8 weeks of inclusion in the study and were
stored in small plastic bags at room temperature. Large
nail clippings were cut into pieces smaller than 9 mm.
The selenium content of the toenails (mean weight
(standard deviation) = 54 (39 mg)) was assessed by a
single measurement by instrumental neutron activation
analysis of the metastable-selenium-77 isotope at a
central laboratory (Interfaculty Reactor Institute,
Technical University, Delft, The Netherlands) (30) by
personnel blinded to disease status, over a period of 2
years. Per center, samples from cases and controls
were analyzed together and randomly distributed over
batches. Samples were irradiated for 17 seconds in a
thermal flux of 1.1 X 10 l7 neutrons/second/cm2. After
a decay time of 20 seconds, gamma radiation of 77mSe
was measured for 30 seconds. Samples were rotated
during irradiation.
The mean level of selenium (n = 87) in certified
bovine liver reference material (NBS-1577A) was
0.76 ± 0.04 ppm (coefficient of variation = 5.3 per-
cent) against a certified value of 0.71 ± 0.07 ppm. Per
batch of 50 samples, two standard reference samples
were included.
, Selenium concentrations were reported in ppm (p,g/
g), and for each sample, an error percentage was
reported as an estimate of the accuracy of the given
value. The error percentage depends on errors in the
measurement of peak areas, uncertainty in the neutron
flux, and uncertainty in the nuclear constants used. For
samples less than 20 mg (n = 196, mean 13 mg ± 4),
the error percentage was 12.3 percent ± 4.5; for sam-
ples of 20 mg or more, the error percentage was 7.4
percent ± 4.0. The limit of detection was defined as
the concentration at which selenium could be detected
with 97.5 percent certainty. The limit of detection
depends on the sample weight. For a sample of 20 mg,
the detection limit was 0.400 ppm; for a sample of
average weight (54 mg), the detection limit was 0.170
ppm.
Data analysis
Toenail clippings were not available for 55 cases
and 23 control individuals. In another nine samples
(four cases, five controls), selenium values were found
to be below the detection level; these were excluded
from data analysis. The prevalence of risk factors of
coronary heart disease among those excluded was
similar to that among the included subjects. Included
were the results of 1,412 persons (683 cases and 729
controls). From 1,309 of these individuals, sufficient
adipose tissue samples could be obtained for reliable
assessment of alpha-tocopherol and beta-carotene. For
11 of the 1,412 persons, information about smoking
habits was incomplete; they were excluded from mul-
tivariate analyses.
Crude means for major risk factors and potential
confounders among cases and controls were calculated
and the difference in means were tested with Student's
t test and chi-square analyses. Median levels of sele-
nium (and the 25th and 75th percentiles) among cases
and controls were computed from the center-specific
distributions. The associations between potential risk
factors and myocardial infarction in the overall control
group were estimated with Pearson and Spearman
correlations and analysis of variance. Selenium values
were log transformed to normalize a skewed distribu-
tion; retransformed values are presented where appli-
cable. Smoking categories included never smokers,
exsmokers, and current smokers. Exsmokers were de-
fined as having stopped smoking 2 or more years
before entering the study. In the logistic regression
models, a variable representing these smoking catego-
ries as well as a continuous variable for the number of
cigarettes smoked daily (zero for never and former
smokers) were included. For multivariate analysis,
multiple logistic regression was used with maximum
likelihood estimation of the regression coefficients and
their standard errors. Per center, the age- and smoking-
adjusted odds ratio of the contrast in selenium level
between the 75th and 25th percentile (among controls)
was calculated, with selenium and age as continuous
variables in the logistic regression model. The overall
data were also stratified for smoking (current, ex-, and
never smokers), and the continuous odds ratio was
estimated, adjusting for age, center, and, for current
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smokers, the number of cigarettes smoked. For the
pooled data, odds ratios were also calculated for the
highest quintile compared with the lowest, based on
the distribution among controls from all centers com-
bined. Tests for trend were performed by assigning
each subject the median value for the category and
treating this value as a continuous variable in the
model (31). All analyses were performed with the
BMDP statistical software package.
RESULTS
The prevalence of coronary heart disease risk fac-
tors in myocardial infarction cases and controls is
given in table 2. Significant crude differences are
observed for age, history of hypertension, smoking,
angina pectoris, diabetes mellitus, family history of
coronary heart disease, and body mass index. Lower
total serum cholesterol concentrations in cases are
almost certainly due to the acute effect of the myocar-
dial infarction. Median selenium concentrations in toe-
nails for cases and controls in the different centers are
shown in table 3. The overall median is 0.553 /xg/g in
cases and 0.590 /xg/g in controls. Highest median level
(in Israel) and lowest median level (in Germany) var-
ied by a factor of almost 2.
The relation of selenium concentration to coronary
heart disease risk factors was examined in controls.
Persons who currently smoked cigarettes had signifi-
cantly lower selenium levels (0.553 /xg/g) than ex-
smokers (0.599 /xg/g) and those who had never
smoked (0.652 /xg/g). The Spearman correlation be-
tween the number of cigarettes smoked daily (among
current smokers only) and selenium was -0.22 (p <
0.01). Individuals with a family history of coronary
TABLE 2. Risk factors for coronary heart dlseasa in cases
wtth acute myocardial Infarction and In control subjects In the
EURAMIC Study, 1991-1992
Risk
actor
Age (years)
Serum cholesterol
(mmo I/liter)
History of hypertension (%)
Current smokers (%)
No. of cigarettes/day
(among smokers)
Angina pectoris (%)
Diabetes mellitus (%)
Family history of CHDt (%)
Alcohol use (%)
Body mass index (kg/m2)
Cases
(/? =
Mean
54.7
5.5
26
58
25
14
8
58
80
26.5
683)
(SDt)
(8.9)
(1.1)
(15)
(3.9)
Controls
( n -
Mean
53.2*
5.6
1 8 "
3 3 "
18**
5 "
4»*
46**
83
25.9*
729)
(SD)
(9.2)
(1.1)
(12)
(3.4)
*p<0.01, **p< 0.001.
t SD, standard deviation; CHD, coronary heart disease.
$ 520 cases and 586 controls.
heart disease had significantly higher selenium levels
than those without a family history of coronary heart
disease (0.623 /xg/g and 0.579 /xg/g, respectively).
Selenium concentration was not associated with
age, total cholesterol, body mass index, angina pecto-
ris, diabetes, alcohol use, or hypertension. There
was either no correlation or a weak correlation be-
tween vitamin E or beta-carotene levels and toenail
selenium (r = -0.04, p = 0.25; r = 0.08, p = 0.03,
respectively).
To evaluate heterogeneity of results across centers,
age- and smoking-adjusted odds ratios were calculated
for each center separately for the center-specific 75th
percentile versus 25th percentile of the selenium dis-
tribution among controls (table 3). For Germany,
where the lowest selenium levels were observed, a
significant inverse association was observed (odds ra-
tio 0.62, 95 percent confidence interval 0.42-0.91).
The odds ratios for the other centers ranged between
0.77 and 1.35 and were not significantly different from
1.0. The interaction of selenium with center was not
significant (p = 0.31).
Next, the age- and center-adjusted odds ratios of
myocardial infarction were calculated for quintiles of
the selenium distribution among controls (table 4).
The odds ratio in the highest selenium quintile was
0.32 (95 percent confidence interval 0.20-0.53, p for
trend < 0.0001). However, after additional adjustment
for smoking, the odds ratio in the highest quintile was
0.63 (95 percent confidence interval 0.37-1.07, p for
trend = 0.08). Inclusion of family history of coronary
heart disease in this model only marginally affected
the odds ratios for selenium. Addition of vitamin E to
the model slightly decreased the risk estimates, and the
trend over quintiles became borderline significant (ta-
ble 4); additional inclusion of beta-carotene did not
change the odds ratios. Although interaction terms of
selenium (in quintiles) with either vitamin E or beta-
carotene (dichotomized) did not improve the fit of the
regression model (p = 0.92 and p = 0.33, respective-
ly), the observed inverse association appeared to be
more pronounced at low vitamin E levels. In persons
with a vitamin E status below the median (< 203
/xg/g), the odds ratio for myocardial infarction at the
highest selenium quintile was 0.45 (95 percent confi-
dence interval 0.23-0.90); in subjects with vitamin E
status above the median, this odds ratio was 0.72
(0.37-1.39).
Selenium was also modeled as a continuous variable
in the logistic regression models. The odds ratios for
the 75th percentile level compared with the 25th per-
centile level were not significantly different from 1.0
after adjustment for smoking and antioxidants (table
4). When including only those centers that used pop-
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TABLE 3. Median toenail selenium concentrations (In }ig/g) by center and disease status and adjusted* odds ratios for
myocardial infarction at high (75th percentile) vs. low (25th percentile) selenium level In the EURAMIC Study, 1991-1992
Germany (Berlin)
Netherlands (Zeist)
Spain (Granada)
Spain (Malaga)
Scotland (Edinburgh)
Swftzerland (Zurich)
Russia (Moscow)
Norway (Sarpsborg)
Finland (Helsinki)
Israel (Jerusalem)
Overall
No.
cases
75
62
54
94
41
57
91
96
57
56
683
No.
controls
96
56
52
100
32
74
98
100
62
59
729
Median
0.430
0.458
0.487
0.504
0.498
0.546
0.633
0.640
0.783
0.872
0.553
Cases
25-75%
0.378-0.467
0.417-0.497
0.443-0.528
0.465-0.555
0.453-0.580
0.501-0.638
0.547-0.724
0.575-0.707
0.699-0.903
0.745-0.950
0.465-0.692
Median
0.452
0.491
0.499
0.531
0.574
0.605
0.643
0.654
0.834
0.868
0.590
Controls
25-75%
0.420-0.511
0.433-0.541
0.454-0.587
0.461-0.604
0.510-0.636
0.531-0.685
0.553-0.715
0.581-0.719
0.769-0.919
0.781-0.957
0.489-0.716
75th vs. 25th percentfls
OR*,t
0.62
0.93
0.74
0.85
0.77
0.78
1.14
1.35
0.87
0.99
0.92
95% Clt
0.42-0.91
0.59-1.46
0.37-1.48*
0.52-1.38
0.38-1.55
0.49-1.25
0.80-1.64
0.96-1.89
0.54-1.41
0.61-1.61
0.74-1.13
* Adjusted for age and smoking by logistic regression.
t OR, odds ratio; Cl, confidence interval.
t To reach convergence, never smokers and exsmokers were combined in the model for Granada.
ulation controls exclusively, the odds ratio was signif-
icantly decreased to 0.65 (0.45-0.94).
Odds ratios for the 75th to 25th percentile of sele-
nium were also calculated separately for current smok-
ers, former smokers, and subjects who had never
smoked. The interaction term of selenium (/xg/g) and
smoking (three categories) in the logistic regression
model was not statistically significant (p = 0.18). An
inverse association was observed in current smokers,
with an odds ratio of 0.86 (0.64-1.16), and former
smokers (odds ratio 0.63 (0.43-0.94)), but not in never
smokers (odds ratio 1.55 (0.87-2.76)). Additional ad-
justment for number of cigarettes smoked daily in
current smokers changed the odds ratio to 0.97 (0.71—
1.32).
DISCUSSION
In this multicenter case-control study, we observed
no significant association between toenail selenium
levels and risk of nonfatal acute myocardial infarction
when smoking habits were taken into account. The
overall data indicated an inverse trend; however, this
appeared to be restricted to exsmokers in stratified
analysis, which may be due to inadequate adjustment
for former smoking habits. With respect to individual
centers, only in Germany, where selenium levels were
the lowest, were low selenium levels associated with a
statistically significant increased risk of myocardial
infarction. The overall inverse trend was more pro-
nounced at low vitamin E status than at high vitamin
E status; however, there was no significant interaction
between selenium and either vitamin E or beta-
carotene.
Toenail selenium represents a measure of dietary
intake over a period of several weeks, close to a year
before the nail was clipped (22). This measure will not
be affected by the acute event of infarction. Major
dietary sources are meat and grain products. Apart
from the diet, smoking habits, gender, and possibly
age are also predictors of toenail selenium levels (21,
32). We adjusted for smoking habits and age in the
calculation of risk estimates.
Low response rates in some of the centers using
population controls may have led to underrepresenta-
tion of smokers in the controls. The stronger associa-
tion for centers using population controls exclusively
compared with the overall population is an indication
for such a phenomenon. However, we are not con-
vinced that there is such selection bias because the
type of control selection did not affect the estimates
for the association between beta-carotene and acute
myocardial infarction, which we have reported previ-
ously (24), although beta-carotene is also an antioxi-
dant that is affected by smoking status. It is also not
very likely that selection bias would result in the
controls having greater dietary intake of selenium,
given the sources of selenium. For beta-carotene, it
would be more likely that selection bias would lead to
greater intakes, through vegetables, in the population
controls. As stated previously, there was no indication
of such selection bias in our beta-carotene results.
Norway and Russia were the only countries with a
risk estimate greater than 1. For other centers, the odds
ratios varied between 0.62 and 0.99, unrelated to
sources of controls. Some selection bias cannot be
excluded, but the direction is likely to be different for
different centers. Therefore we feel it is prudent to
base our conclusions on the pooled data, not on se-
lected subsets.
Evidence for an association between serum sele-
nium and risk of coronary heart disease has not been
conclusive so far. An early report of an inverse asso-
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ciation between serum selenium and coronary heart
disease (4) has been confirmed by two prospective
studies (3, 5). Virtamo et al. (3) reported an increased
risk of cardiovascular death (relative risk 1.6) but not
of myocardial infarction (relative risk 1.1) at serum
selenium levels less than 45 /xg/liter, which is ex-
tremely low. The more recent study by Suadicani et al.
(5) shows an adjusted relative risk of ischemic heart
disease of 1.55 at levels less than 1 /xmol/liter (about
79 jig/liter). Adjustment for smoking was done for the
categories never, ex-, and current smokers, which may
leave some residual confounding. Several other pro-
spective studies have found no association between
serum selenium and coronary heart disease (7-10). In
two of these nested case-control studies (9, 10) report-
ing relative risks of 1.0 for serum selenium less than
1.45 p-mol/liter and 0.9 for levels less than 45 /xg/liter,
respectively, subjects were matched on smoking hab-
its. Kok et al. (8) reported a relative risk of 1.1 for
coronary deaths at low selenium levels. Toenail sele-
nium levels of myocardial infarction cases were found
to be significantly lower than in controls in a study in
the Netherlands (33); the adjusted odds ratio for myo-
cardial infarction at the lowest quartile of toenail se-
lenium compared with the highest was 4.5 (95 percent
confidence interval 1.3-15.7). Smoking was modeled
as a dichotomous variable, so in this study as well,
residual confounding by smoking may be possible. A
case-control study from New Zealand (6) reported an
increased risk of myocardial infarction at low sele-
nium levels, which was confined to smokers. Again,
this finding might be due in part to insufficient adjust-
ment for smoking behavior (smoking yes/no). More-
over, serum selenium levels were determined in blood
drawn directly after the infarction, which may have
affected the levels in cases, although the authors report
results from a pilot study showing no decrease of
serum selenium immediately after the event.
The range of toenail selenium levels observed in this
European study is much larger and levels are lower
than those reported for different areas in the United
States. The median levels of our lowest and highest
quintile vary by a factor of 2. Hunter et al. (21)
reported the lowest levels (adjusted for age, smoking,
and supplement use) among participants in the Nurses'
Health Study in Maryland (0.770 /ig/g) and the high-
est in Texas (0.877 /xg/g). Overall average levels for
the United States were 0.801 /ig/g for non-supplement
users and 0.906 /xg/g for supplement users, which
were comparable with the highest quintile of our Eu-
ropean population.
In conclusion, it appears that the increased risk of
acute myocardial infarction at low levels of selenium
intake is largely explained by cigarette smoking; vari-
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ability in selenium status does not appear to be an
important determinant of risk of myocardial infarction
at the levels observed in a large part of Europe and in
the United States.
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